Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/- ModelInfections and Atheromatous Plaque: Current Therapeutic ImplicationsNeurobiology of Sleep Disturbances in Neurodegenerative DisordersInnate Immunity in Lophotrochozoans: The AnnelidsThe Antioxidants and Pro-Antioxidants Network: An OverviewReplication and Transcription of the Rotavirus GenomeVirus attachment and entry offer numerous targets for antiviral therapy.The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzymeIn vivo bio-imaging using chlorotoxin-based conjugatesWnt/beta-catenin signaling and small molecule inhibitorsThe natural tumor suppressor protein maspin and potential application in non small cell lung cancerDevelopmental and pathogenic mechanisms of basement membrane assemblyCardiac applications for human pluripotent stem cellsResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceTherapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancerTopiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.The VHL tumor suppressor: master regulator of HIF5-HT3 receptorsPotential therapeutic interest of adenosine A2A receptors in psychiatric disorders.The pharmacology of cyclic nucleotide-gated channels: emerging from the darknesssiRNA Delivery by Stimuli-Sensitive NanocarriersAdvances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum DisorderNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesRecent Advances of Radionuclide-Based Molecular Imaging of AtherosclerosisThe chemical and biological aspects of fluoroquinolones: reality and dreamsVascular protection to increase the safety of tissue plasminogen activator for strokeEpithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistanceMesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapyBridge between neuroimmunity and traumatic brain injuryWhen ubiquitin meets NF-κB: a trove for anti-cancer drug developmentAMPK as a potential anticancer target - friend or foe?Review: modifications of human serum albumin and their binding effectThe redox biology of schistosome parasites and applications for drug developmentPerspectives on new synthetic curcumin analogs and their potential anticancer propertiesCholine analogues in malaria chemotherapyAntihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approachesMucin-based targeted pancreatic cancer therapyTargeting UDP-galactopyranose mutases from eukaryotic human pathogensNon-systemic drugs: a critical reviewBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke
P1433
Q21558460-33E7EFD1-E214-4357-AFC4-565BCC286EA8Q22241412-EE95444B-3616-4454-B029-D8B8EEA2FB73Q22305793-7EB83309-A9D2-48CF-8794-C8E2EF37A130Q22305794-D2053979-D36C-479B-AAE5-4A6BCC26B5CDQ22305802-4638F84B-4F22-4E52-8EB7-719E84031DFDQ22305803-8F677CB8-0902-47B2-A1A8-FBADD2DA7443Q22923697-1E13A1F6-BC1F-46BE-AF39-EAE9CDDF318CQ24316066-CAB18FD0-204C-42D9-9E2D-FEB205BB27E7Q24595399-D3DCE0FF-B698-4A4D-B70A-37EDC277E0EBQ24597197-D6E8A981-A96D-467F-9919-929F62BB3B6DQ24604273-5D03D6E7-4FF2-4F34-8AD7-121B2F4F5EDEQ24608109-67050399-569C-4D38-9504-58E14AF96A3DQ24615347-0ECF53A6-D5A9-409E-86D3-51D68FF2351BQ24618313-38586A22-6ED1-4395-8830-4B17C5864AEBQ24621214-D03A8485-25CE-449A-BE04-4CA7488CBCEDQ24632593-383EFA94-43AD-4644-AB04-66DB3C1F54D3Q24634592-7BF8579A-DCA9-44AE-8515-83FD9D388926Q24648000-D239416B-195A-4FD3-AE78-B1F5E7215A44Q24657796-D9A7BF33-FAEE-414A-9388-2ACFD58627A0Q24657946-235DF30F-D712-4C47-A260-76E82CEA451BQ26781212-94DB8379-939F-4678-9525-92CFF077EA51Q26781265-2B50F834-820F-4193-A59C-1A173A074CABQ26786162-505609AE-5239-49B7-9ACD-A918E5DB0E2CQ26787117-A9D4B72E-CA07-4AE3-B681-1D030DB7988CQ26810046-EB19C86D-82B1-45C9-A368-83CA5AAF6C6DQ26824338-97E37EFE-875D-47DE-8398-F26A027A5EA8Q26824386-46E15DB3-EF6B-4E4E-B856-CBF95D93955EQ26825272-3B134210-3E5A-4747-8D23-3388A8EE3779Q26827612-92ACC327-7117-4E4F-AEFE-AECE0AF9B226Q26827754-12096F46-DFD5-4728-9FE5-E4E5DA3E2D04Q26829427-E5C3CEC5-1E61-4623-B3BE-14529C5BA791Q26829605-8D3308F4-8977-4770-BE55-2373C7223C94Q26829701-A3526EBF-770D-4D4D-BE2F-F7FDC821DDC3Q26851248-D452313E-4D9D-48A6-84AC-6DF461AEC9ACQ26851323-78CDB8B5-2E35-4B98-B078-9A4D8F35391AQ26861570-EFC88CFD-86FB-490F-8BDF-3F3BD1B88854Q26861761-0455F61E-2F26-4F9D-A499-0AAA3AB3EF30Q26862107-35A7ACC0-C6DF-49C5-95F4-BE66879A15EEQ26863371-5328B935-3AAD-4224-8747-5D69E215BCCEQ26864317-C951C94A-EEE4-4DD7-B975-09C8634E42F9
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Current Pharmaceutical Design
@ast
Current Pharmaceutical Design
@da
Current Pharmaceutical Design
@de
Current Pharmaceutical Design
@en
Current Pharmaceutical Design
@es
Current Pharmaceutical Design
@fi
Current Pharmaceutical Design
@fr
Current Pharmaceutical Design
@it
Current Pharmaceutical Design
@nb
Current Pharmaceutical Design
@nl
type
label
Current Pharmaceutical Design
@ast
Current Pharmaceutical Design
@da
Current Pharmaceutical Design
@de
Current Pharmaceutical Design
@en
Current Pharmaceutical Design
@es
Current Pharmaceutical Design
@fi
Current Pharmaceutical Design
@fr
Current Pharmaceutical Design
@it
Current Pharmaceutical Design
@nb
Current Pharmaceutical Design
@nl
prefLabel
Current Pharmaceutical Design
@ast
Current Pharmaceutical Design
@da
Current Pharmaceutical Design
@de
Current Pharmaceutical Design
@en
Current Pharmaceutical Design
@es
Current Pharmaceutical Design
@fi
Current Pharmaceutical Design
@fr
Current Pharmaceutical Design
@it
Current Pharmaceutical Design
@nb
Current Pharmaceutical Design
@nl
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Curr. Pharm. Des.
P1250
P1277
P1476
Current Pharmaceutical Design
@en
P236
P243
P3181
P407
P571
1995-01-01T00:00:00Z